Maccarrone M et al. |
Estrogen stimulates arachidonoylethanolamide release from human endothelial cells and platelet activation. |
2002 |
Blood |
pmid:12393387
|
González S et al. |
Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. |
2002 |
Brain Res. |
pmid:12393235
|
Milton NG |
Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide. |
2002 |
Neurosci. Lett. |
pmid:12384227
|
Barthó L et al. |
Nitric oxide is involved in the relaxant effect of capsaicin in the human sigmoid colon circular muscle. |
2002 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:12382081
|
Roberts LA et al. |
Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons. |
2002 |
Br. J. Pharmacol. |
pmid:12359623
|
Wallace MJ et al. |
Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. |
2002 |
Eur. J. Pharmacol. |
pmid:12359270
|
Laine K et al. |
Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid. |
2002 |
Invest. Ophthalmol. Vis. Sci. |
pmid:12356827
|
Ralevic V et al. |
Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular function. |
2002 |
Life Sci. |
pmid:12354577
|
Oz M et al. |
Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5-HT3 receptor-mediated responses in Xenopus oocytes. |
2002 |
Synapse |
pmid:12325042
|
Kozak KR et al. |
Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. |
2002 |
J. Biol. Chem. |
pmid:12244105
|
Schuel H et al. |
Evidence that anandamide-signaling regulates human sperm functions required for fertilization. |
2002 |
Mol. Reprod. Dev. |
pmid:12237954
|
Rueda D et al. |
The endocannabinoid anandamide inhibits neuronal progenitor cell differentiation through attenuation of the Rap1/B-Raf/ERK pathway. |
2002 |
J. Biol. Chem. |
pmid:12237305
|
Anikwue R et al. |
Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta(9)-tetrahydrocannabinol administration. |
2002 |
J. Pharmacol. Exp. Ther. |
pmid:12235269
|
Burstein SH et al. |
Regulation of anandamide tissue levels by N-arachidonylglycine. |
2002 |
Biochem. Pharmacol. |
pmid:12234618
|
Plant LD et al. |
Hypoxic depolarization of cerebellar granule neurons by specific inhibition of TASK-1. |
2002 |
Stroke |
pmid:12215606
|
Someya A et al. |
Arachidonic acid release and prostaglandin F(2alpha) formation induced by anandamide and capsaicin in PC12 cells. |
2002 |
Eur. J. Pharmacol. |
pmid:12206851
|
Kagaya M et al. |
Characterization of the anandamide induced depolarization of guinea-pig isolated vagus nerve. |
2002 |
Br. J. Pharmacol. |
pmid:12183329
|
Randall MD et al. |
Cardiovascular effects of cannabinoids. |
2002 |
Pharmacol. Ther. |
pmid:12182966
|
Hansen HS et al. |
Putative neuroprotective actions of N-acyl-ethanolamines. |
2002 |
Pharmacol. Ther. |
pmid:12182959
|
Goutopoulos A and Makriyannis A |
From cannabis to cannabinergics: new therapeutic opportunities. |
2002 |
Pharmacol. Ther. |
pmid:12182958
|
Andersson DA et al. |
Mechanisms underlying tissue selectivity of anandamide and other vanilloid receptor agonists. |
2002 |
Mol. Pharmacol. |
pmid:12181448
|
Gubellini P et al. |
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. |
2002 |
J. Neurosci. |
pmid:12177188
|
Chemin J et al. |
Neuronal T-type alpha 1H calcium channels induce neuritogenesis and expression of high-voltage-activated calcium channels in the NG108-15 cell line. |
2002 |
J. Neurosci. |
pmid:12177183
|
van der Stelt M et al. |
Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase. |
2002 |
J. Med. Chem. |
pmid:12166944
|
Barnett-Norris J et al. |
Conformational memories and the endocannabinoid binding site at the cannabinoid CB1 receptor. |
2002 |
J. Med. Chem. |
pmid:12166938
|
de Lago E et al. |
UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide. |
2002 |
Eur. J. Pharmacol. |
pmid:12163112
|
Costa B et al. |
Chronic treatment with the endocannabinoid anandamide increases cytochrome P450 metabolizing system in the rat. |
2002 |
Eur. J. Pharmacol. |
pmid:12163107
|
Schäbitz WR et al. |
Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study. |
2002 |
Stroke |
pmid:12154273
|
Matias I et al. |
Presence and regulation of the endocannabinoid system in human dendritic cells. |
2002 |
Eur. J. Biochem. |
pmid:12153574
|
Habayeb OM et al. |
Endogenous cannabinoids: metabolism and their role in reproduction. |
2002 |
Life Sci. |
pmid:12148689
|
Di Marzo V et al. |
Endovanilloid signaling in pain. |
2002 |
Curr. Opin. Neurobiol. |
pmid:12139983
|
Liu WM et al. |
Effects of anandamide on embryo implantation in the mouse. |
2002 |
Life Sci. |
pmid:12137909
|
Dinh TP et al. |
Brain monoglyceride lipase participating in endocannabinoid inactivation. |
2002 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:12136125
|
Szallasi A |
Vanilloid (capsaicin) receptors in health and disease. |
2002 |
Am. J. Clin. Pathol. |
pmid:12109845
|
Sugiura T and Waku K |
Cannabinoid receptors and their endogenous ligands. |
2002 |
J. Biochem. |
pmid:12097154
|
Vinklerová J et al. |
Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251. |
2002 |
J. Psychopharmacol. (Oxford) |
pmid:12095072
|
Kirkham TC et al. |
Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. |
2002 |
Br. J. Pharmacol. |
pmid:12055133
|
Di Marzo V et al. |
Anandamide receptors. |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052051
|
Högestätt ED and Zygmunt PM |
Cardiovascular pharmacology of anandamide. |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052048
|
Pinto L et al. |
Endocannabinoids and the gut. |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052047
|
Fride E |
Endocannabinoids in the central nervous system--an overview. |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052038
|
Deutsch DG et al. |
The fatty acid amide hydrolase (FAAH). |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052036
|
Fowler CJ and Jacobsson SO |
Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide--targets for drug development? |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052035
|
Sugiura T et al. |
Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052034
|
Mechoulam R |
Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression. |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052029
|
Kreitzer AC and Regehr WG |
Retrograde signaling by endocannabinoids. |
2002 |
Curr. Opin. Neurobiol. |
pmid:12049940
|
Williams CM and Kirkham TC |
Observational analysis of feeding induced by Delta9-THC and anandamide. |
2002 |
Physiol. Behav. |
pmid:12044596
|
Farquhar-Smith WP et al. |
Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors. |
2002 |
Pain |
pmid:12031775
|
Smart D et al. |
'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism. |
2002 |
Br. J. Pharmacol. |
pmid:12023948
|
Porter AC et al. |
Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. |
2002 |
J. Pharmacol. Exp. Ther. |
pmid:12023533
|
Ross RA et al. |
Pharmacological characterization of the anandamide cyclooxygenase metabolite: prostaglandin E2 ethanolamide. |
2002 |
J. Pharmacol. Exp. Ther. |
pmid:12023517
|
Maccarrone M et al. |
Binding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cells. |
2002 |
Biochem. J. |
pmid:12010121
|
Romero J et al. |
Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study. |
2002 |
Brain Res. Mol. Brain Res. |
pmid:12008024
|
Mukhopadhyay S et al. |
Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent. |
2002 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:12003810
|
Maccarrone M et al. |
Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour. |
2002 |
Eur. J. Neurosci. |
pmid:11982628
|
Gerdeman GL et al. |
Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. |
2002 |
Nat. Neurosci. |
pmid:11976704
|
Ishii I and Chun J |
Anandamide-induced neuroblastoma cell rounding via the CB1 cannabinoid receptors. |
2002 |
Neuroreport |
pmid:11973452
|
Gardiner SM et al. |
Complex regional haemodynamic effects of anandamide in conscious rats. |
2002 |
Br. J. Pharmacol. |
pmid:11959791
|
Bisogno T et al. |
Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications. |
2002 |
Curr. Pharm. Des. |
pmid:11945157
|
Hansen HS et al. |
When and where are N-acylethanolamine phospholipids and anandamide formed? |
2001 |
World Rev Nutr Diet |
pmid:11935960
|
Ueda N et al. |
Alkaline and acid amidases hydrolyzing anandamide and other N-acylethanolamines. |
2001 |
World Rev Nutr Diet |
pmid:11935959
|
Valk P et al. |
Enhancement of erythropoietin-stimulated cell proliferation by Anandamide correlates with increased activation of the mitogen-activated protein kinases ERK1 and ERK2. |
2000 |
Hematol. J. |
pmid:11920199
|
Walter L et al. |
Astrocytes in culture produce anandamide and other acylethanolamides. |
2002 |
J. Biol. Chem. |
pmid:11916961
|
Lin YS and Lee LY |
Stimulation of pulmonary vagal C-fibres by anandamide in anaesthetized rats: role of vanilloid type 1 receptors. |
2002 |
J. Physiol. (Lond.) |
pmid:11897863
|
Harris D et al. |
Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bed. |
2002 |
J. Physiol. (Lond.) |
pmid:11897858
|
Molina-Holgado F et al. |
Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures. |
2002 |
J. Neurosci. Res. |
pmid:11891798
|
Wenger T et al. |
The hypothalamic levels of the endocannabinoid, anandamide, peak immediately before the onset of puberty in female rats. |
2002 |
Life Sci. |
pmid:11883716
|
Ford WR et al. |
Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilatator responses in rat isolated hearts. |
2002 |
Br. J. Pharmacol. |
pmid:11877326
|
Luo C et al. |
Anandamide inhibits excitatory transmission to rat substantia gelatinosa neurones in a manner different from that of capsaicin. |
2002 |
Neurosci. Lett. |
pmid:11872246
|
Di Marzo V et al. |
A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid. |
2002 |
J. Pharmacol. Exp. Ther. |
pmid:11861807
|
Hayase T et al. |
Protective effects of cannabinoid receptor ligands analogous to anandamide against cocaine toxicity. |
2001 |
Nihon Arukoru Yakubutsu Igakkai Zasshi |
pmid:11828716
|
Maccarrone M et al. |
Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer. |
2002 |
Mol. Hum. Reprod. |
pmid:11818522
|
Laine K et al. |
Effect of the enzyme inhibitor, phenylmethylsulfonyl fluoride, on the IOP profiles of topical anandamides. |
2002 |
Invest. Ophthalmol. Vis. Sci. |
pmid:11818382
|
Mechoulam R et al. |
Cannabinoids and brain injury: therapeutic implications. |
2002 |
Trends Mol Med |
pmid:11815270
|
Martin BR et al. |
Assessment of structural commonality between tetrahydrocannabinol and anandamide. |
2002 |
Eur. J. Pharmacol. |
pmid:11790376
|
Lever IJ and Malcangio M |
CB(1) receptor antagonist SR141716A increases capsaicin-evoked release of Substance P from the adult mouse spinal cord. |
2002 |
Br. J. Pharmacol. |
pmid:11786475
|
Ros J et al. |
Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. |
2002 |
Gastroenterology |
pmid:11781284
|
Izzo AA et al. |
The gastrointestinal pharmacology of cannabinoids. |
2001 |
Curr Opin Pharmacol |
pmid:11757815
|
Begg M et al. |
Modulation of the release of endogenous gamma-aminobutyric acid by cannabinoids in the guinea pig ileum. |
2002 |
Eur. J. Pharmacol. |
pmid:11755170
|
Darmani NA |
The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids. |
2002 |
J. Pharmacol. Exp. Ther. |
pmid:11752094
|
Al-Hayani A et al. |
The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice. |
2001 |
Neuropharmacology |
pmid:11747904
|
Chemin J et al. |
Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. |
2001 |
EMBO J. |
pmid:11742980
|
López-RodrÃguez ML et al. |
Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors. |
2001 |
J. Med. Chem. |
pmid:11741470
|
Molderings GJ et al. |
Noradrenaline release-inhibiting receptors on PC12 cells devoid of alpha(2(-)) and CB(1) receptors: similarities to presynaptic imidazoline and edg receptors. |
2002 |
Neurochem. Int. |
pmid:11738482
|
Wagner JA et al. |
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. |
2001 |
J. Am. Coll. Cardiol. |
pmid:11738314
|
Hayase T et al. |
Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-induced toxic behavioural symptoms. |
2001 |
J. Pharm. Pharmacol. |
pmid:11732755
|
Stamer WD et al. |
Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues. |
2001 |
Eur. J. Pharmacol. |
pmid:11730719
|
Karava V et al. |
Anandamide amidohydrolase activity, released in the medium by Tetrahymena pyriformis. Identification and partial characterization. |
2001 |
FEBS Lett. |
pmid:11728445
|
Gurwitz D and Weizman A |
Fatty acid amide hydrolase inhibitors and the marijuana debate. |
2001 |
Lancet |
pmid:11705595
|
Jamshidi N and Taylor DA |
Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. |
2001 |
Br. J. Pharmacol. |
pmid:11704633
|
RodrÃguez de Fonseca F et al. |
An anorexic lipid mediator regulated by feeding. |
2001 |
Nature |
pmid:11700558
|
van der Stelt M et al. |
Exogenous anandamide protects rat brain against acute neuronal injury in vivo. |
2001 |
J. Neurosci. |
pmid:11698588
|
Bifulco M et al. |
Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth. |
2001 |
FASEB J. |
pmid:11687506
|
Grainger J and Boachie-Ansah G |
Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels. |
2001 |
Br. J. Pharmacol. |
pmid:11682448
|
Nogueron MI et al. |
Cannabinoid receptor agonists inhibit depolarization-induced calcium influx in cerebellar granule neurons. |
2001 |
J. Neurochem. |
pmid:11677265
|
Kurihara J et al. |
2-Arachidonoylglycerol and anandamide oppositely modulate norepinephrine release from the rat heart sympathetic nerves. |
2001 |
Jpn. J. Pharmacol. |
pmid:11676206
|
Ralevic V et al. |
Cannabinoid activation of recombinant and endogenous vanilloid receptors. |
2001 |
Eur. J. Pharmacol. |
pmid:11672565
|
Berdyshev EV et al. |
Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. |
2001 |
FASEB J. |
pmid:11641243
|
White R et al. |
Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries. |
2001 |
Br. J. Pharmacol. |
pmid:11606334
|
Bisogno T et al. |
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. |
2001 |
Br. J. Pharmacol. |
pmid:11606325
|